ERBA Diagnostics (ERB) to Delay 10-K Filing; Notes Continued Trouble Completing Financial Statements

ERBA Diagnostics (NYSE: ERB) announced that it is delaying the filing of its Annual Report on Form 10-K for the year ended December 31, 2014 with the Securities and Exchange Commission (the "SEC").

As previously disclosed in the Notification of Late Filing on Form 12b-25, which ERBA Diagnostics filed with the SEC on April 1, 2015, ERBA Diagnostics delayed filing its Annual Report on Form 10-K because of unforeseen delays in connection with completing and filing its consolidated financial statements and the accompanying footnotes. Until these matters can be resolved, ERBA Diagnostics will not be in a position to file its Annual Report on Form 10-K with the SEC.

Pursuant to Rule 12b-25 under the Securities Exchange Act of 1934, ERBA Diagnostics received an extension until April 15, 2015 to file its Annual Report on Form 10-K for the year ended December 31, 2014, which extension has now expired. ERBA Diagnostics is working diligently to complete and file its Annual Report on Form 10-K with the SEC, which ERBA Diagnostics expects to do on or about April 30, 2015.

You May Also Be Interested In

• Fisker (FSR) files form 10-K, sees more job cuts, reiterates going concern doubts
• Scilex Holding (SCLX) Prices 15M Share Offering at $1/sh
• Staffing 360 Solutions (STAF) Receives Nasdaq Non-compliance Notice